NICCOLAI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 4.128
EU - Europa 3.508
AS - Asia 844
OC - Oceania 54
AF - Africa 23
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.564
Nazione #
US - Stati Uniti d'America 4.108
PL - Polonia 1.165
RU - Federazione Russa 1.118
IT - Italia 455
IE - Irlanda 300
SG - Singapore 217
HK - Hong Kong 215
SE - Svezia 208
CN - Cina 149
IN - India 69
FI - Finlandia 67
ID - Indonesia 59
AU - Australia 54
JO - Giordania 54
DE - Germania 44
VN - Vietnam 41
GB - Regno Unito 36
NL - Olanda 25
FR - Francia 23
CA - Canada 15
CH - Svizzera 14
CI - Costa d'Avorio 14
ES - Italia 14
TR - Turchia 14
BE - Belgio 9
UA - Ucraina 8
CZ - Repubblica Ceca 5
DK - Danimarca 5
MX - Messico 5
UG - Uganda 5
AT - Austria 4
IR - Iran 4
KR - Corea 4
LT - Lituania 4
PK - Pakistan 4
CO - Colombia 3
PH - Filippine 3
BR - Brasile 2
IL - Israele 2
JP - Giappone 2
KG - Kirghizistan 2
MA - Marocco 2
TW - Taiwan 2
AM - Armenia 1
AR - Argentina 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IQ - Iraq 1
IS - Islanda 1
NO - Norvegia 1
RO - Romania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 8.564
Città #
Warsaw 1.164
Santa Clara 1.156
Fairfield 449
Dublin 298
Chandler 265
Ashburn 225
Seattle 205
Woodbridge 192
Singapore 183
Houston 180
Cambridge 173
Hong Kong 166
Florence 127
Wilmington 125
Lawrence 108
Altamura 106
Ann Arbor 93
Princeton 82
Jakarta 56
Melbourne 52
Mumbai 49
Beijing 48
Boston 45
San Diego 37
Moscow 32
Dong Ket 30
Medford 28
New York 28
Shanghai 28
Boardman 25
Helsinki 25
Buffalo 22
Rome 18
West Jordan 16
Hillsboro 15
Munich 15
Abidjan 14
Fiesole 14
Kent 14
Bern 13
Pune 12
Yubileyny 12
Los Angeles 11
Toronto 10
Brussels 9
Barcelona 8
Falls Church 8
London 8
Ho Chi Minh City 7
Jacksonville 7
Council Bluffs 6
Falkenstein 6
Phoenix 6
Bologna 5
Brno 5
Frankfurt am Main 5
Guangzhou 5
Izmir 5
Kampala 5
Lappeenranta 5
Milan 5
Paris 5
Redwood City 5
Segromigno in Monte 5
Washington 5
Andover 4
Arezzo 4
Bagno a Ripoli 4
Cagliari 4
Genoa 4
Karachi 4
Nijmegen 4
Seoul 4
Timonium 4
Vienna 4
Bari 3
Bogotá 3
Chicago 3
Dearborn 3
Edmonton 3
Frederiksberg 3
Hangzhou 3
Makassar 3
Norwalk 3
Pistoia 3
Prescot 3
San Francisco 3
San Giovanni Valdarno 3
Santa Ana 3
Scarperia e San Piero 3
Sesto Fiorentino 3
Viareggio 3
Agliana 2
Albany 2
Amsterdam 2
Arzachena 2
Atlanta 2
Aubagne 2
Aversa 2
Bishkek 2
Totale 6.198
Nome #
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 293
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 269
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 237
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 228
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 216
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 200
Studio della risposta T immuno-specifica in corso di tumori dell'apparato digerente 192
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 187
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 169
Evaluation and comparison of short chain fatty acids composition in gut diseases 163
Thrombosis in vasculitis: from pathogenesis to treatment 161
Gastric cancer and the epoch of immunotherapy approaches 150
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 148
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 141
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 139
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 131
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 129
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 129
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 129
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 128
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 128
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 127
Designing a broad-spectrum integrative approach for cancer prevention and treatment 122
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 121
Novel immunotherapeutic strategies of gastric cancer treatment 116
Broad targeting of resistance to apoptosis in cancer 114
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 109
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 103
Microparticles: Bridging the gap between autoimmunity and thrombosis 102
Cancer prevention and therapy through the modulation of the tumor microenvironment 101
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 99
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 98
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. 97
Broad targeting of angiogenesis for cancer prevention and therapy 97
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds 96
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 96
Machine learning for analysis of gene expression data in fast- and slow-progressing amyotrophic lateral sclerosis murine models 96
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 95
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 94
Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies 94
Nourishing Immunity and Combatting Neuroinflammation: The Power of Immunonutrition and The Microbiome 93
A multi-targeted approach to suppress tumor-promoting inflammation 93
What is recent in pancreatic cancer immunotherapy? 92
T cells, tissue factor and malignancy 92
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 92
Role of immune response in yersinia pestis infection. 89
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 88
Circulating miRNome profiling data in Behçet's syndrome 87
HELICOBACTER PYLORI HP0175 PROMOTES THE PRODUCTION OF IL-23, IL-6, IL-1 beta AND TGF-beta 82
Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy 80
Gastritis in Helicobacter pylori infection 78
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition 77
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 76
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 76
Therapeutic targeting of replicative immortality 75
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 75
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 75
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 68
GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin 68
Differential Diagnosis 67
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 66
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 65
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 63
Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study 63
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 62
Plant and Marine Sources: Biological Activity of Natural products and therapeutic Use 61
Exploring Plasma-Level Gut Microbiota Mediators and Pro-Inflammatory Markers in Pregnant Women with Short Cervix and Gestational Diabetes Mellitus 59
The first taxonomic and functional characterization of human CAVD-associated microbiota 58
Utilization of formalin-fixed paraffin-embedded specimens for microbiota characterization in cancer: utility and concern 58
Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation 56
Alterations of circulating free fatty acids in patients with pemphigus vulgaris 55
Adverse Effects of Micro- and Nanoplastics on Humans and the Environment 52
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 52
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 49
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 49
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 44
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 44
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 43
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 42
Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease 41
Rummeliibacillus suwonensis: First Time Isolation from Human Feces by Culturomics 41
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes 40
Dysregulated metabolism contributes to oncogenesis 37
The Future Exploring of Gut Microbiome-Immunity Interactions: From In Vivo/Vitro Models to In Silico Innovations 35
Cytokine and microbiota profiles in obesity-related hypertension patients 34
Six-Month Synbio® Administration Affects Nutritional and Inflammatory Parameters of Older Adults Included in the PROBIOSENIOR Project 33
Gut-lung microbiota dynamics in mice exposed to Nanoplastics 33
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 31
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers 29
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy 26
Rheumatic diseases: The microbiota-immunity axis in development and treatment 25
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 24
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice 21
Potential Association of the Oral Microbiome with Trimethylamine N-Oxide Quantification in Mexican Patients with Myocardial Infarction 21
Experimental tests challenge the evidence of a healthy human blood microbiome 10
Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment 5
Totale 8.794
Categoria #
all - tutte 27.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020616 0 0 0 0 0 0 126 144 122 92 105 27
2020/2021826 71 95 33 91 53 58 54 62 72 146 42 49
2021/2022483 14 22 75 25 4 22 14 66 17 18 62 144
2022/20231.335 120 317 70 73 74 202 183 71 134 21 31 39
2023/2024690 19 56 107 36 42 112 33 124 11 69 29 52
2024/20253.278 132 442 291 692 1.127 534 60 0 0 0 0 0
Totale 8.794